RecruitingNot Applicable

Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain

United States126 participantsStarted 2025-10-01

Plain-language summary

Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient has localized knee pain * Must be an appropriate candidate for arterial vascular access procedure Exclusion Criteria: * Known sensitivity or allergy to implant materials * Unable or unwilling to comply with study requirements

What they're measuring

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

Timeframe: 6 and 12-month post treatment

Serious Adverse Events (SAE)

Timeframe: Treatment, 1,3,6,9 and 12-month post treatment

Trial details

NCT IDNCT06872567

SponsorNorth American Science Associates Ltd.

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2026-06

Contact for this trial

Ziv J Haskal, MD

16463691570 haskalembo@gmail.com

View on ClinicalTrials.gov More Knee Osteoarthritis (Knee OA) trials